The effects of microglia on tauopathy progression can be quantified using Nexopathy in silico (Nexis) models

Abstract The prion-like transsynaptic propagation of misfolded tau along the brain’s connectome has previously been modeled using connectome-based network diffusion models. In addition to the connectome, interactions between the general neurological “milieu” in the neurodegenerative brain and protei...

Full description

Bibliographic Details
Main Authors: Chaitali Anand, Pedro D. Maia, Justin Torok, Christopher Mezias, Ashish Raj
Format: Article
Language:English
Published: Nature Portfolio 2022-12-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-25131-3
_version_ 1811203994035421184
author Chaitali Anand
Pedro D. Maia
Justin Torok
Christopher Mezias
Ashish Raj
author_facet Chaitali Anand
Pedro D. Maia
Justin Torok
Christopher Mezias
Ashish Raj
author_sort Chaitali Anand
collection DOAJ
description Abstract The prion-like transsynaptic propagation of misfolded tau along the brain’s connectome has previously been modeled using connectome-based network diffusion models. In addition to the connectome, interactions between the general neurological “milieu” in the neurodegenerative brain and proteinopathic species can also contribute to pathology propagation. Such a molecular nexopathy framework posits that the distinct characteristics of neurodegenerative disorders stem from interactions between the network and surrounding molecular players. However, the effects of these modulators remain unquantified. Here, we present Nexopathy in silico (“Nexis”), a quantitative model of tau progression augmenting earlier models by including parameters of pathology propagation defined by the molecular modulators of connectome-based spread. Our Nexis:microglia model provides the first quantitative characterization of this effect on the whole brain by expanding previous models of neuropathology progression by incorporating microglial influence. We show that Trem2, but not microglial homeostasis genes, significantly improved the model’s predictive power. Trem2 appears to reduce tau accumulation rate while increasing its interregional spread from the hippocampal seed area, causing higher tau burden in the striatum, pallidum, and contralateral hippocampus. Nexis provides an improved understanding and quantification of microglial contribution to tau propagation and can be flexibly modified to include other modulators of progressive neurodegeneration.
first_indexed 2024-04-12T03:05:20Z
format Article
id doaj.art-c6858ce3cdbe4a7fba1d24dbce41a9be
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-12T03:05:20Z
publishDate 2022-12-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-c6858ce3cdbe4a7fba1d24dbce41a9be2022-12-22T03:50:32ZengNature PortfolioScientific Reports2045-23222022-12-0112111410.1038/s41598-022-25131-3The effects of microglia on tauopathy progression can be quantified using Nexopathy in silico (Nexis) modelsChaitali Anand0Pedro D. Maia1Justin Torok2Christopher Mezias3Ashish Raj4Department of Radiology, University of California San FranciscoDepartment of Mathematics, University of Texas at ArlingtonDepartment of Radiology, University of California San FranciscoDepartment of Neuroscience, Cold Spring Harbor LaboratoryDepartment of Radiology, University of California San FranciscoAbstract The prion-like transsynaptic propagation of misfolded tau along the brain’s connectome has previously been modeled using connectome-based network diffusion models. In addition to the connectome, interactions between the general neurological “milieu” in the neurodegenerative brain and proteinopathic species can also contribute to pathology propagation. Such a molecular nexopathy framework posits that the distinct characteristics of neurodegenerative disorders stem from interactions between the network and surrounding molecular players. However, the effects of these modulators remain unquantified. Here, we present Nexopathy in silico (“Nexis”), a quantitative model of tau progression augmenting earlier models by including parameters of pathology propagation defined by the molecular modulators of connectome-based spread. Our Nexis:microglia model provides the first quantitative characterization of this effect on the whole brain by expanding previous models of neuropathology progression by incorporating microglial influence. We show that Trem2, but not microglial homeostasis genes, significantly improved the model’s predictive power. Trem2 appears to reduce tau accumulation rate while increasing its interregional spread from the hippocampal seed area, causing higher tau burden in the striatum, pallidum, and contralateral hippocampus. Nexis provides an improved understanding and quantification of microglial contribution to tau propagation and can be flexibly modified to include other modulators of progressive neurodegeneration.https://doi.org/10.1038/s41598-022-25131-3
spellingShingle Chaitali Anand
Pedro D. Maia
Justin Torok
Christopher Mezias
Ashish Raj
The effects of microglia on tauopathy progression can be quantified using Nexopathy in silico (Nexis) models
Scientific Reports
title The effects of microglia on tauopathy progression can be quantified using Nexopathy in silico (Nexis) models
title_full The effects of microglia on tauopathy progression can be quantified using Nexopathy in silico (Nexis) models
title_fullStr The effects of microglia on tauopathy progression can be quantified using Nexopathy in silico (Nexis) models
title_full_unstemmed The effects of microglia on tauopathy progression can be quantified using Nexopathy in silico (Nexis) models
title_short The effects of microglia on tauopathy progression can be quantified using Nexopathy in silico (Nexis) models
title_sort effects of microglia on tauopathy progression can be quantified using nexopathy in silico nexis models
url https://doi.org/10.1038/s41598-022-25131-3
work_keys_str_mv AT chaitalianand theeffectsofmicrogliaontauopathyprogressioncanbequantifiedusingnexopathyinsiliconexismodels
AT pedrodmaia theeffectsofmicrogliaontauopathyprogressioncanbequantifiedusingnexopathyinsiliconexismodels
AT justintorok theeffectsofmicrogliaontauopathyprogressioncanbequantifiedusingnexopathyinsiliconexismodels
AT christophermezias theeffectsofmicrogliaontauopathyprogressioncanbequantifiedusingnexopathyinsiliconexismodels
AT ashishraj theeffectsofmicrogliaontauopathyprogressioncanbequantifiedusingnexopathyinsiliconexismodels
AT chaitalianand effectsofmicrogliaontauopathyprogressioncanbequantifiedusingnexopathyinsiliconexismodels
AT pedrodmaia effectsofmicrogliaontauopathyprogressioncanbequantifiedusingnexopathyinsiliconexismodels
AT justintorok effectsofmicrogliaontauopathyprogressioncanbequantifiedusingnexopathyinsiliconexismodels
AT christophermezias effectsofmicrogliaontauopathyprogressioncanbequantifiedusingnexopathyinsiliconexismodels
AT ashishraj effectsofmicrogliaontauopathyprogressioncanbequantifiedusingnexopathyinsiliconexismodels